FDA Program Cuts Loom If ‘Cures’ Bill Isn’t Fully Funded, Ostroff Warns
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s acting commissioner says agency may have to ‘stop doing something else’ in order to cover the new responsibilities envisioned in the Cures legislation.